AHA committee report. Ethics of biomedical technology transfer Committee on Ethics.
Modern biomedical research creates a cascade of startlingly effective forms of diagnostics and therapeutics. Modern communication makes public awareness immediate and public demand insatiable. Many of these new advances, because of expense, sophistication, inaccessibility, or latent danger, must be considered scarce. The Ethics Committee of the American Heart Association recognizes the ethical allocation of these scarce resources as the most difficult, demanding, and unresolved problem facing the American Medical profession. It is apparent that the genesis of the problem is in another area fraught with different but equally complex ethical problems, that of the development and transfer of biomedical technology. The following statement is an analysis of the ethics of the development and transfer of biomedical technology which serves as a foundation for the further consideration of the ethical allocation of scarce medical resources.
D003362:Cost-Benefit Analysis; D028663:Ethical Theory; D004992:Ethics, Medical; D033161:Government Regulation; D006801:Humans; D013677:Medical Laboratory Science / Q000191:economics; D026706:Paternalism; D012106:Research; D040841:Resource Allocation; D012926:Social Control, Formal; D012945:Social Values; D013673:Technology Assessment, Biomedical